|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.0000 - 0.0000|
|52 Week Range|
|Beta (3Y Monthly)||-0.51|
|PE Ratio (TTM)||0.01|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
GreenGro Technologies, Inc. (GRNH), a world-class provider of eco-friendly green technologies, today announced the launch of its newly formed CBD Subsidiary, EMS Meds, Inc., which will focus on the research and development of a full line of premium CBD products that will be distributed directly to doctors’ offices, medical facilities and specialty retailers. EMS Meds will serve as the GreenGro’s clinical arm dedicated to the production of CBD-based medicines and treatments. GreenGro noted that its targeted distribution network, which should be covered by most insurance carriers, will make its CBD products available to a large number of patients who until today could not afford CBD-derived medications.
ANAHEIM, Calif., Oct. 03, 2018 -- GreenGro Technologies, Inc. (OTC: GRNH), an established provider of eco-friendly green technologies, today announced that a leading.
Gala Pharmaceutical, Inc. (GLPH), an emerging cannabis testing company, today announced it expects to form strategic alliances with GreenGro Technologies (GRNH), a developer of eco-friendly greenhouses, and igot420distribution, a network of distribution centers connecting farms and manufacturing labs to licensed medical and recreational dispensaries, to boost initial demand for Gala Pharmaceutical’s cannabis testing facilities. Under the terms of the agreements, over the next several months, the three companies will collaborate to develop a joint sales, marketing and distribution strategy that will collectively take them one step closer towards becoming a true vertically integrated solution provider for the cannabis industry. “Our partnerships with GreenGro Technologies and igot420 distribution will enable Gala Pharmaceutical to further develop and leverage our marketing and sales efforts to strengthen our position in the emerging market for cannabis testing facilities,” said Dr. Rehman, Chief Executive Officer of Gala Pharmaceutical, Inc. “These alliances will allow us to gain access to their deep-rooted and extensive client relationships across the cannabis industry, which will rapidly boost demand for our cannabis testing facilities as the state continues to phase in new cannabis testing regulations throughout the year,” concluded Dr. Rehman.
Irvine, California, Aug. 22, 2018-- via NEWMEDIAWIRE-- County Line Energy Corp. today announced that D5 Partners, Inc., CYLC’ s wholly-owned operating subsidiary, has entered into an Advisory Agreement ...